Pharvaris N.V. (PHVS) intrinsic value & 10-year financials
Pharvaris N.V. (PHVS) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- -52.1%
- Free cash flow (FY2025)
- -€137.2M
PHVS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -€175.7M | -€2.97 | -€137.2M | — | -64.5% |
| FY2024 | — | -€134.2M | -€2.48 | -€120.7M | — | -40.6% |
| FY2023 | — | -€100.9M | -€2.63 | -€93.1M | — | -37.4% |
| FY2022 | — | -€76.3M | -€2.27 | -€67.3M | — | -42.7% |
| FY2021 | — | -€42.7M | -€1.40 | -€44.7M | — | -28.4% |
| FY2020 | — | -€26.0M | — | -€21.5M | — | -45.4% |
| FY2019 | — | -€8.0M | — | -€6.7M | — | -68.0% |
| FY2018 | — | -€4.3M | — | — | — | -89.8% |
| FY2017 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in EUR.
Executive summary
Pharvaris N.V. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Pharvaris N.V. 10-year average ROIC is N/A; capital efficiency cannot be assessed from the available history.
Pharvaris N.V. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Pharvaris N.V. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.